Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Market Cap	754.18M -21.6%
Revenue (ttm)	833.52M -7.9%
Net Income	77.13M -27.7%
EPS	0.08 -26.4%
Shares Out	n/a
PE Ratio	9.78
Forward PE	6.85
Dividend	0.04 (4.76%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	0.7550
Previous Close	0.7850
Day's Range	0.7550 - 0.7550
52-Week Range	0.7500 - 1.0900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 1,643
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GEKA

Financial Performance

In 2025, Genomma Lab Internacional's revenue was 17.54 billion, a decrease of -5.73% compared to the previous year's 18.61 billion. Earnings were 1.61 billion, a decrease of -23.13%.

Financial numbers in MXN